3558 results for «384»
3558 results
What is new in radial access in 2025
20 May 2025 – From EuroPCR 2025
Explore the latest developments in radial access for PCI as of 2025. Topics include distal versus conventional transradial access, techniques to reduce forearm complications, sheathless approaches, dual artery compression methods, and feasibility in high bleeding risk patients.
Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice
21 May 2025 – From EuroPCR 2025
This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...
Challenging scenarios in acute coronary syndrome
20 May 2025 – From EuroPCR 2025
This session presents challenging acute coronary syndrome (ACS) cases with unusual presentations and complications. Learn from cases involving myocarditis mimics, coronary aneurysms, rescue fibrinolysis during PCI, and STEMI complicated by cardiogenic shock, highlighting diagnostic and therapeutic nuances.
New perspectives in 3D calcium visualisation with CT and angiography for complex PCI
21 May 2025 – From EuroPCR 2025
Thanks to this EuroPCR 2025 session, discover new perspectives on 3D calcium visualisation combining advanced imaging techniques like 3DStent, IVUS, and 3D angiography to enhance complex PCI. Learn from detailed calcium mapping and plaque assessment to guide strategic decisions and see these innovations applied in practice...
DCB in de novo lesions: new valid option?
20 May 2025 – From EuroPCR 2025
Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.
Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?
22 May 2025 – From EuroPCR 2025
Discover how the novel Hertz Contact Intravascular Lithotripsy (IVL) is pushing the boundaries of calcium modification in challenging coronary lesions.
This EuroPCR 2025 session shares real-world insights confirming the promising results of the PINNACLE I trial, with LithiX IVL proving safe and effective across eccentric, concentric, and...
Best companion's case on complications for stable coronary artery disease PCI: episode 1
20 May 2025 – From EuroPCR 2025
This session focuses on managing complications during PCI for stable coronary artery disease through real-world case presentations. Topics include severe dissections, unexpected procedural complications, and escalation of routine interventions, providing practical insights for complication navigation.
Optimal management of high bleeding risk patient with multivessel disease
21 May 2025 – From EuroPCR 2025
This session offers a comprehensive overview of the management of high bleeding risk (HBR) patients with multivessel disease. Through expert discussion and a live case demonstration featuring a complex elderly patient, it highlights how intracoronary imaging and physiology can guide procedural decisions and improve outcomes in this...
TAVI - Procedural complications
20 May 2025 – From EuroPCR 2025
Review procedural complications encountered during TAVI, including rare adverse events, management of balloon rupture, annulus rupture with tamponade, and unexpected intraoperative challenges. Gain insights into innovative rescue techniques and decision-making under critical conditions.
Optimising self-expandable TAVI clinical outcomes without compromise
22 May 2025 – From EuroPCR 2025
Optimising patient outcomes in self-expandable TAVI starts with a clear plan for today, and tomorrow. This EuroPCR 2025 session explores how to make each step count, from access to implantation and closure, using a real-life case of a 77-year-old woman with severe symptomatic aortic stenosis and...
Primary PCI outside of the box: unusual STEMI cases
20 May 2025 – From EuroPCR 2025
This session presents unusual STEMI cases managed with primary PCI outside conventional protocols. Cases include heavily calcified lesions, STEMIs with non-flow-limiting stenoses, simultaneous occlusions with cardiac arrest, and other complex presentations, highlighting diverse interventional strategies.
Pioneering innovation in the treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...
Outcome prediction using artificial intelligence and meta-analysis
22 May 2025 – From EuroPCR 2025
This session presents outcome prediction advancements through artificial intelligence and meta-analysis in cardiology. Topics include AI-guided aortic stenosis risk stratification, predictors of periprocedural stroke after TAVI, patient-specific computer simulations for bicuspid TAVI, and enhancements in large language model accuracy using Heart Team simulation.
TAVI in bicuspid aortic valve disease
22 May 2025 – From EuroPCR 2025
Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.
Imaging makes it clear!
22 May 2025 – From EuroPCR 2025
Explore the critical role of intravascular imaging in interventional cardiology through real-world cases. This session highlights the value of intravascular ultrasound (IVUS) in avoiding unnecessary stenting in STEMI patients, the application of optical coherence tomography (OCT) in complex scenarios, and the management of calcified lesions with...
Advanced tools for the diagnosis of coronary artery disease
22 May 2025 – From EuroPCR 2025
This session highlights advanced diagnostic tools for coronary artery disease, focusing on innovative pressure gradient assessments, computed tomography perfusion accuracy in stented patients, head-to-head comparisons of IQ-FFR with invasive FFR, and comprehensive evaluations of coronary physiology and plaque vulnerability derived from angiography.
Redefining the red flags: early detection of myocardial infarction in women
22 May 2025 – From EuroPCR 2025
Gain a unique patient-centered perspective on early myocardial infarction detection in women. This session features a survivor's story, collaborative step-by-step clinical approaches, and key aspects of cardiac rehabilitation, emphasizing shared decision-making to improve patient outcomes in complex cases.
Patients with degenerated aortic bioprothesis - Every case is different
22 May 2025 – From EuroPCR 2025
Delve into the nuanced management of patients with degenerated aortic bioprostheses, emphasizing that no two cases are alike. This session provides expert insights into selecting optimal valve-in-valve TAVI approaches tailored to individual anatomy and clinical context. Learn practical strategies to overcome complex challenges such as coronary...
TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation
22 May 2025 – From EuroPCR 2025
Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.
New frontier in renal denervation: data, devices and developments
22 May 2025 – From EuroPCR 2025
Advance your understanding of renal denervation with the latest data, innovative devices, and emerging developments. This session reviews the 12-month results of the REDUCED 1 trial evaluating the TIVUS system, explores safety and efficacy of novel renal stimulation techniques, and presents outcomes from registries including patients...
